Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 519.47% and ...

Good morning. Eli Lilly and Company has promoted longtime executive Lucas Montarce to the role of CFO. The move is similar to ...

The latest installment of the “Stop Weight Bias” campaign has brought aboard Eli Lilly ... As sales of Lilly’s GLP-1 medications have continued to skyrocket, the company has made a point ...

Eli Lilly and Company reported third quarter results and missed expectations and had to lower its guidance, which was a huge disappointment for investors. But in the last few years, Eli Lilly was ...

Eli Lilly and Company (NYSE: LLY) today announced that data from studies of Jaypirca® (pirtobrutinib), a non-covalent (reversible) Bruton's tyrosine kinase (BTK) inhibitor, will be presented at ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best rising stocks to invest In now. The market experts believe that Q3 2024 saw stocks ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other momentum stocks. After the Fed's rate cut and a positive inflation report ...

Eli Lilly is dialing back its 2024 forecast after underwhelming Wall Street with third-quarter earnings and sales from two ...

BioCrossroads has named Eli Lilly CEO, Dave Ricks, the recipient of the 2024 August M. Watanabe Life Sciences Champion of the ...

Eli Lilly executives insisted that underlying demand for the medicines remained strong and that the company has enough supply available. During an earnings call Wednesday, Eli Lilly instead blamed ...